Media Releases

Oxfam reacts to the UN Global Humanitarian Plan for 2022

December 2, 2021

In reaction to the launch today of the UN Global Humanitarian Plan for 2022, Oxfam Global Programs Director, Lydia Zigomo, said:

“Around the world today, humanitarian need is at its highest-ever level, and what is worse is that the international community has long known all the terrible causes behind it. The people who are most in need of help have been ignored as rich nations have turned inwards in response to the COVID-19 crisis – hording vaccines, continuing their huge carbon emissions, and closing their borders to those seeking safety.

Around 274 million people worldwide, many of whom are women and girls, are experiencing unimaginable suffering because of three lethal Cs – climate change, conflict and COVID-19. They urgently need help. For this reason, the UN is asking for the world’s largest appeal to date, a 17 percent increase compared to last year, and rich nations must step up to avoid a catastrophic failure ahead.

Oxfam calls upon all governments, especially the rich nations who are most responsible for the climate crisis and vaccine inequality, to fulfil their obligations and channel more funding to match the humanitarian need and help immediately to save lives. Governments and the international community must ensure a more coordinated response to help communities rebuild their lives, ensuring that women and local organisations on the frontline of the humanitarian response are better funded.”

Notes

Oxfam’s Global Program Director is at the meeting and available for interviews
The Global Humanitarian Overview (GHO) 2022 launches on 2 December in Geneva. It is the world’s most comprehensive humanitarian assessment. The report will be available on the report website: gho.unocha.org.
The UN Global Humanitarian Overview 2022 can be found at https://gho.unocha.org/
Photos with captions and UNifeed video
The launch is aired live on UN Web TV here.

New database addresses lack of transparency about financial intermediary investments of IFC and FMO

December 1, 2021

A coalition of organisations has published a new database today revealing US $38.2 billion worth of investment and financial relationships – including “high-risk” projects – that involve 318 financial intermediary clients of Dutch development bank FMO and the World Bank’s private lending arm, the IFC.

The organisations that crunched the database numbers are Oxfam, economic research agency Profundo, the International Accountability Project and the Early Warning System.

The database is important in countering claims by big development institutions like FMO and IFC that such information is “commercially confidential” and that it is too difficult for them to meet the levels of transparency demanded by civil society and local communities who may be harmfully affected by these lending projects.

The database reveals the destination of investments from FMO and IFC-funded clients across at least 76 countries from 2017-20. In total, the database tracks the money flows from FMO and IFC down through the 318 financial intermediaries to 12,800 private actors.

The IFC and FMO are both heavily involved in this growing form of development financing, where development banks invest directly into third-party “financial intermediaries” like hedge funds and commercial banks via loans, equity and guarantees, on the premise it will extend their financial reach and raise standards. In 2020 around 60% – or US $6.7 billion – of the IFC’s entire investment portfolio was exposed via financial intermediaries, and around 40% or €3.7 billion for the FMO.

However, these financial intermediary clients of IFC and FMO invest in different development activities including “high-risk projects” with the potential to harm people and the environment, such as companies involved in mining and oil extraction projects.

There is growing evidence of such harmful projects like the Sesan dam in Cambodia that flooded out entire villages and the New Liberty Gold Mine in Liberia which displaced people, exacerbated poverty and polluted local water sources. These projects were funded via FMO or IFC intermediary clients, but affected communities were not adequately consulted or given access to information in order to seek redress.

“FMO’s lack of transparency about their investments in financial institutions makes it impossible to monitor whether environmental and social standards are being enforced. The lack of clarity about where FMO’s money ends up makes it very difficult to determine the impact of these investments. But above all, it means that local communities affected by risky or harmful projects are unable to find out who is behind the investments, what protection they can demand and where to find redress,” said Imke Greven, land rights expert Oxfam Novib.

“Local communities do not have access to this kind of information about financial flows. Access to such information is a human right in itself, and this database can play an important role in that. Failure to publish such information by development banks and their financial intermediaries is a choice. This newly developed database shows that it is possible,” said Ryan Schlief, Executive Director International Accountability Project.

“It is appalling that development finance institutions still don’t disclose such basic information. There is no reason for them to make it so hard to allow access to such basic information when they should have it as part of their due diligence and make it accessible,” said Christian Donaldson, Senior Policy Advisor at Oxfam International.

“Last year, the IFC became the first institution to commit to disclose this information on its website, even though we are still waiting for that to happen. We strongly encourage other development finance institutions to follow suit. This database shows it is perfectly possible to do so,” Donaldson said.

“For NGOs to develop this database is a time-consuming and costly process due to the limited resources and limited information available to them. As such, the database represents only the tip of the iceberg since researchers don’t have access to the internal accounts of the financial institutions and the resources available to the development banks. The research has shown that it is possible to provide detailed financial intermediary disclosure. Now it is up to the DFIs to do so themselves,” said Ward Warmerdam, Senior Financial Researcher, Profundo.

World Trade Organisation talks on vaccines postponed due to concerns over the spread of a new variant of COVID-19

November 30, 2021

Responding to the announcement that World Trade Organisation talks on vaccines due to take place in Geneva next week have been postponed due to concerns over the spread of a new variant of COVID-19 which has emerged in South Africa, People’s Vaccine Alliance spokesperson and Oxfam health Policy Manager, Anna Marriott, said:

“The vaccine apartheid that rich countries and the World Trade Organisation have refused to address is ultimately responsible for the decision to postpone these talks.

“It should be a stain on the conscience of those who have blocked the waiver of Intellectual Property that South Africa is now facing the threat of a dangerous new virus variant with less than a quarter of its population fully vaccinated, especially given the fact the country has been so vocal in calling for the waiver which would allow more vaccines to be produced globally.

“There can be no more delays, putting pharmaceutical profits before people’s lives is clearly a risk to us all. We do not need a ministerial summit to agree to this, we just need governments to put the good of humanity above the profits of a handful of companies.”

The Ignored Pandemic Report

November 25, 2021

A new Oxfam report shows an undeniable increase in gender-based violence (GBV) during the COVID-19 pandemic around the world to which too many governments and donors are not doing enough to tackle.

The report, The Ignored Pandemic: The Dual Crisis of Gender-Based Violence and COVID-19, showed the number of calls made by survivors to domestic violence hotlines in ten countries during the first months of lockdown. The data reveals a 25 – 111 percentage surge; in Argentina (25%), Colombia (79%), Tunisia (43%), China (50%), Somalia (50%), South Africa (69%), UK (25%), Cyprus (39%), Italy (73%) and the largest increase in Malaysia where calls surged by over 111%.

In many households, coronavirus has created a ‘perfect storm’ of social and personal anxiety, stress, economic pressure, social isolation, including with abusive family members or partners, and rising alcohol and substance use, resulting in increases in domestic abuse.

Meanwhile, India too recorded an increase of 250 percent of domestic violence cases, according to the National Commission for Women. Domestic violence counselors there reported being unable to reach women and girls who were grievously injured or suicidal or those whose partners controlled their access to phones.

The report shows that not enough countries have acted with sufficient seriousness to tackle the GBV pandemic. Even before the surge in GBV cases sparked by the pandemic, in 2018 alone, over 245 million women and girls were subjected to sexual or physical violence by an intimate partner – a greater number than the global total of coronavirus cases (199m) between October 2020 and October 2021.

“It is a scandal that millions of women and girls, and LGBTQIA+ people have to live through this double pandemic of violence and COVID-19. GBV has led to injuries, emotional distress, and increasing poverty and suffering, all of which are utterly inexcusable and avoidable. The pandemic has exposed the systematic failure of governments around the world to protect women and girls and LGBTQIA+ people from violence against them – simply because of who they are,” said Oxfam International Executive Director Gabriela Bucher.

Women’s rights organisations whose mission is to support women and girls and LGBTQIA+ people from violence have been more likely to have been hit by funding cuts, exactly at the time when their work is most needed. In an Oxfam survey published in June this year, over 200 women’s rights organisations across 38 countries reported reduced funding and shrinking access to decision-making spaces. Thirty-three percent had to lay off between one to ten staff, while nine percent had to close altogether.

Even though 146 UN member states have formally declared their support for action against GBV in their COVID-19 response and recovery plans, only a handful have followed through. Of the $26.7 trillion that governments and donors mobilised to respond to the pandemic in 2020, just 0.0002% has gone into combating GBV.

“The pandemic has worsened long-standing gender discriminations, and this has increased the vulnerability of women and girls and LGBTQIA+ people to violence and abuse. If governments do not deliberately initiate strong, properly funded strategies to tackle this, the gains made in women’s empowerment in the last 30 years are at risk. We need to avert this, and the time is now,” said Bucher.

A few governments, however, have made efforts to respond to the GBV crisis. For instance, Indonesia and New Zealand introduced national protocols and identified GBV service providers as essential workers. South Africa took steps to strengthen GBV reporting channels.

The 16 Days of Activism against Gender-Based Violence that commences today until 10 December 2021 provides an opportunity for governments, donors, and activists to reflect on the emerging issues of inequality that put women and girls at risk and address them urgently. The COVID-19 pandemic has shown that governments can take extraordinary measures to protect their citizens and respond to deadly crises when spurred to action. We need to see more efforts to tackle gender-based violence.

Oxfam recommends that states and governments ensure a more coordinated, comprehensive, and multi-sectoral GBV response that enables survivors to access effective and quality services. Governments and donors should channel more funding to women’s rights organisations and feminist movements working to end GBV and support survivors. Additionally, more funding should be allocated to better data collection and analysis of gender-disaggregated national statistics to inform evidence-based interventions to end GBV.

“As the world comes together to mark 30 years of the 16 Days of Activism against Gender-Based Violence, there is an urgent need for a truly gendered approach in every country’s effort to respond to and recover from COVID-19. Governments and donors need to live up to their commitments to promote gender equality by ensuring investment in all the areas we know could help end GBV. Only by doing so can we strive for a future that is more just, safe, and in which people live free from discrimination,” said Bucher.

Notes:

The 16 Days of Activism against Gender-Based Violence is an annual international event that runs for 16 days from 25^th November, the International Day for the Elimination of violence against women, until 10^th December, Human Rights Day. This year’s event marks 30 years since its first commemoration in 1991. The event is a platform used by organisations and activists globally to call for the prevention and elimination of violence against women and girls.

The data on calls to domestic/GBV helplines in ten low, middle- and high-income countries during the first wave of the COVID-19 pandemic has been compiled from different UN, national and international NGO reports and government sources. The increase in call volumes is presented as a range between the lowest and highest percentage value among the different countries.

For more information or an interview, contact:

Florence Ogola, in Nairobi florence.ogola@oxfam.org +254 733770522

Read the report: https://policy-practice.oxfam.org/publications/the-ignored-pandemic-the-dual-crises-of-gender-based-violence-and-covid-19-621309

Pfizer, BioNTech and Moderna making US$1,000 profit every second while world’s poorest countries remain largely unvaccinated

November 16, 2021

Demand grows for firms to share vaccine recipes and technology as billionaire pharma bosses convene for ‘Big Pharma Davos’

New figures from the Peoples Vaccine Alliance reveal that the companies behind two of the most successful COVID vaccines – Pfizer, BioNTech and Moderna – are making combined profits of US$65,000 (NZ$92,000) every minute. The figures based on the latest company reports are released as CEOs from pharmaceutical industry meet for the annual STAT summit – the equivalent of a ‘Big Pharma Davos’ – from 16 – 18 November.

These companies have sold the majority of doses to rich countries, leaving low income countries out in the cold. Pfizer and BioNTech have delivered less than one percent of their total vaccine supplies to low-income countries, while Moderna has delivered just 0.2 percent. Meanwhile 98 percent of people in low income countries have not been fully vaccinated.

Maaza Seyoum of the African Alliance and People’s Vaccine Alliance Africa said: “It is obscene that just a few companies are making millions of dollars in profit every single hour, while just two percent of people in low-income countries have been fully vaccinated against coronavirus.

“Pfizer, BioNTech and Moderna have used their monopolies to prioritise the most profitable contracts with the richest governments, leaving low income countries out in the cold.”

Despite receiving public funding of over US$8 billion, the three corporations have refused calls to urgently transfer vaccine technology and know-how with capable producers in low- and middle-income countries via the World Health Organisation (WHO), a move that could increase global supply, drive down prices and save millions of lives. In Moderna’s case, this is despite explicit pressure from the White House and requests from the WHO that the company collaborate in and help accelerate its plan to replicate the Moderna vaccine for wider production at its mRNA hub in South Africa.

While Albert Bourla, the CEO of Pfizer, described the call to share vaccine recipes ‘dangerous nonsense,’ the WHO emergency use approval of the Indian vaccine Covaxin earlier this month is clear evidence that developing countries have the capacity and expertise.

Anna Marriott, Oxfam’s Health Policy Manager said: “Contrary to what Pfizer’s CEO says, the real nonsense is claiming the experience and expertise to develop and manufacture life-saving medicines and vaccines does not exist in developing countries. This is just a false excuse that pharmaceutical companies are hiding behind to protect their astronomical profits.

“It is also a complete failure of government to allow these companies to maintain monopoly control and artificially constrain supply in the midst of a pandemic while so many people in the world are yet to be vaccinated.”

Based on company financial statements, the Alliance estimates that Pfizer, BioNTech and Moderna will make pre-tax profits of US$34 billion this year between them, which works out as over a thousand dollars a second, US$65,000 a minute or US$93.5 million a day. The monopolies these companies hold have produced five new billionaires during the pandemic, with a combined net wealth of US$35.1 billion.

The People’s Vaccine Alliance, which has 80 members including the African Alliance, Global Justice Now, Oxfam, and UNAIDS, is calling for the pharmaceutical corporations to immediately suspend intellectual property rights for COVID vaccines, tests, treatments, and other medical tools by agreeing to the proposed waiver of the TRIPS Agreement at the World Trade Organisation.

They are also calling on governments, including the United States, to use all their legal and policy tools to demand that pharmaceutical companies share COVID-19 data, know-how, and technology with the WHO’s COVID-19 Technology Access Pool and South Africa mRNA Technology Transfer Hub.

More than 100 nations, led by South Africa and India – with the support of the US – have been calling for the TRIPS waiver, which also has the support of over 100 past and present world leaders and Nobel laureates.

Despite this, other rich nations, including the UK and Germany, are still blocking the proposal, putting the interest of pharmaceutical companies over what’s best for the world. This issue is set to dominate the World Trade Organisation Ministerial Summit to be held in Geneva from 30 November to 3 December.

Notes to editors:

A People’s Vaccine Alliance report from 21 October found that Moderna has only delivered 0.2 percent of their total vaccine supply to low-income countries and Pfizer/BioNTech has delivered less than 1
In their Q3 financial statement, Pfizer forecast US$36bn in vaccine revenue for 2021. Gross profit from the revenue is split 50/50 with BioNTech. Pfizer guidance for their income before tax (after splitting profit with BioNTech) is ‘High-20s as a Percentage of Revenues.’ A conservative 25% margin would bring Pfizer’s profit before tax to US$9bn in 2021 from the Comirnaty Covid vaccine.
In BioNTech’s Q3 financial statement they forecast €16-17 billion in vaccine revenue for 2021. In the 9 months ending September 30 the company made € 10.3bn profit before tax on €13.4bn, revenue giving a 77% profit margin. Using a conservative €16bn forecasted revenue for the full year, we therefore estimate that at a 77% profit margin, BioNTech will make €12.3bn in pre-tax profit in 2021 – or US$14.7bn using the 2021 average exchange rate.
Moderna’s Q3 profit before tax for 9 months ending September 30 is US$7.8bn on US$11.2bn revenue giving a pre-tax profit margin of 70%. The company projects full year 2021 sales to be “between US$15 billion and US$18 billion”. Using the lower end of the estimate – 70% of US$15bn is US$10.5bn in profit for 2021. The vaccine is Moderna’s only commercial product.
We therefore estimate the combined 2021 profit before tax for Moderna and Pfizer and BioNTech as US$34bn. There are 525600 minutes in a year giving US$ 64,961 profit before tax per minute or US$1,083 per second. Pre-tax, rather than net, profit is used as Pfizer only report the guidance for pre-tax profit margin.
One New Zealand dollar is worth approximately 70 US cents.

Oxfam: New Zealand must do more for PNG – urgently

November 16, 2021

Papua New Guinea faces a deadly pandemic of misinformation

In response to the New Zealand government sending a medical and logistics support team to Papua New Guinea (PNG) over the weekend, Oxfam Aotearoa says that while essential supplies and support is a good contribution, the government can, and must, do more.

Oxfam Aotearoa Communications and Advocacy Director Dr Jo Spratt said:

“Recently, we heard Hon. Minister Mahuta outline how Aotearoa would partner with Pacific countries to achieve resilience. Referring to our Pacific neighbours as family, the Minister recognised our deep and enduring whakapapa connections – Tātai Hono, and reiterated the importance of Tātou Tātou – all of us together. If there is any time to put these values into action, it is when one of our family members is experiencing a severe humanitarian crisis. This support from the government is a good start, but more needs to be done and urgently.”

Oxfam Papua New Guinea Country Director Eunice Wotene says that as the third coronavirus wave escalates out of control in the country, people are experiencing a lot of challenges. There are multiple issues over Covid-19 vaccinations, lockdowns, and an overwhelmed health system further perpetuating an already stressful situation.

In an effort to control the outbreak, the PNG government has put in place control measures banning gatherings of more than 20 people and encouraging the general public to follow the “Niupela Pasin” (new normal). Provincial Controllers like that of the Eastern Highland Province have implemented travel restrictions across the borders between districts. Wotene says that control measures implemented at the provincial level have helped reduce the spread of infection and has resulted in a reduction in the number of cases presenting at the hospital. However, this has also caused challenges and restricted people from getting to vaccination centres. It has also created economic challenges for people because they can’t get to markets, sell their produce, and earn an income to sustain themselves. This has, in turn, led to an increase in other social issues like petty crimes.

Thousands of doses of the AstraZeneca and Johnson & Johnson vaccines have been coming into PNG from neighbouring countries, but despite the large number of vaccines, PNG is struggling to get its vaccination rates above 9 per cent. Wotene says that while vaccines are welcome and needed, people are either misinformed about the risks, or unable to get vaccines:

“The situation is complicated. Many of our people live in remote rural villages. Information and vaccines aren’t reaching them, and travel restrictions between district borders make things difficult. For some people, even if they could make it to a clinic, they aren’t going because of the misinformation out there about the vaccines’ side-effects. There is a real sense of urgency now that we must do all we can to reach these people.

“In some villages, two or more family members have died from Covid-19, just days or weeks apart. We have a health system overcome with sick people and our people are dying.”

Local and international media recently reported that due to Port Moresby morgues being overwhelmed with the dead, PNG authorities had no choice but to approve mass burial.

New World Bank research, titled Addressing Vaccine Hesitancy: Survey and Experimental Evidence from Papua New Guinea, examined the motivation behind vaccine hesitancy in Papua New Guinea and tested various means of increasing people’s willingness to receive a Covid-19 vaccine. The report found that one of the main hurdles for Papua New Guineans was the fear of the vaccine itself. However, people’s replies also indicated they were open to learning more, particularly if information came from health workers. The research showed that when people were given basic information on the safety of the vaccine and the dangers of Covid-19 that increased the percentage of people who said they were willing to be vaccinated.

Wotene said: “We need health workers to go to the people to provide useful and factual information and help ease their fears. There is also need for mobile clinics where people from the rural communities can be reached for vaccination.”

Dr Spratt said: “In addition to the recent support and supplies, the NZ government should send new emergency funding to support the PNG government and other development partners to rapidly roll-out vaccine information campaigns across the country. This could be done through village health workers, local radio stations and other locally-appropriate communication methods.

“New Zealand still has millions of spare AstraZeneca and Janssen vaccines that we are not using here. We can and should donate these to PNG.”

Ends

Notes:

See the full report Addressing Vaccine Hesitancy: Survey and Experimental Evidence from Papua New Guinea